Athira Pharma, Inc. (ATHA) Misses Q3 EPS by 5c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q3 EPS of ($0.75), $0.05 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Wolfe Research Upgrades Janux Therapeutics (JANX) to Outperform, 'An ARM Out of the Penalty Box'
• Telsey Starts Reformation Inc (REF) at Underperform
• Trend Micro Incorporated (4704:JP) (TMICY) PT Lowered to JPY5,900 at Goldman Sachs